Health
Futura Medical up almost a fifth after it says it is making commercial and regulatory headway
Futura Medical PLC (LON:FUM) shares shot higher after it said it had made regulatory progress in the US and was...
Read more
Synairgen plans after £80m share sale to fund crucial trial of breakthrough COVID-19 drug
Synairgen PLC's Richard Marsden (LON:SNG) talks to Proactive London's Katie Pilbeam about the £80m share placing to finance its lead...
Read more
Open Orphan moves forward with government-backed COVID-19 vaccine human challenge study
Open Orphan PLC’s (LON:ORPH) hVIVO arm has this week been confirmed as key player in the quest for a COVID-19...
Read more
C4X Discovery raises £15mln to assist with partnership discussions
C4X Discovery Holdings PLC (LON:C4XD) has raised a total of around £15mln, before expenses, to strengthen its balance sheet while...
Read more
Open Orphan signs UK government contract to development COVID-19 Human Challenge Study Model
Open Orphan's (LON:ORPH) Chairman Cathal Friel talks to Proactive London after announcing a contract with the UK Government for the...
Read more
SkinBioTherapeutics looks forward to first revenues in 2021
There’s good bacteria and bad bacteria: while we often focus on pushing the latter away, we forget the estimated 100...
Read more
IXICO revenues’ rise for fourth consecutive year, up by 26%
IXICO PLC's (LON:IXI) Giulio Cerroni talks to Proactive London about his artificial intelligence-driven data analytics company. Cerroni explains the latest...
Read more
Pfizer hopes to produce 100mln COVID-19 vaccine doses before 2021
Pfizer Inc. (NYSE:PFE) is hoping to manufacture and distribute 100mln doses of the COVID-19 vaccine it is developing with BioNTech...
Read more
Synairgen gets house broker upgrade after impressive fundraise
House broker finnCap has raised its price target on Synairgen PLC to 420p (LON:SNG) following its fundraise and managed access...
Read more
Amryt Pharma cheers orphan designation for pre-clinical skin treatment
What the company does Amryt Pharma PLC (LON:AMYT) sells and develops orphan drugs used to treat rare diseases with two...
Read more
IQ-AI’s Imaging Biometrics at the forefront of brain tumour analysis
What IQ-AI does: IQ-AI Limited (LON:IQAI) is the company formerly known as Flying Brands. The name change reflected its aspiration...
Read more
Synairgen successfully closes £80mln share sale to fund pivotal trial and manufacturing of breakthrough COVID-19 drug
Synairgen PLC (LON:SNG) said it has successfully concluded an £80mln share placing, providing the financial backing to take its lead...
Read more
